Longitudinal Assessment of Cardiac Function Following Multisystem Inflammatory Syndrome in Children Associated with
Nikkan Das1, Rachel Hill2, Mira Trivedi2
1UPMC Children's Hospital of Pittsburgh, 4401 Penn Ave, Pittsburgh, PA, 15224, USA. dasn2@upmc.edu.
Insights
Multisystem inflammatory syndrome in children (MIS-C) often involves heart issues. While ejection fraction typically recovers, abnormal global longitudinal strain persists in some, indicating potential ongoing subclinical dysfunction.
Area of Science:
- Pediatric Cardiology
- Infectious Diseases
- Critical Care Medicine
Background:
- Multisystem inflammatory syndrome in children (MIS-C) following COVID-19 frequently presents with cardiac complications.
- Myocardial dysfunction, evidenced by reduced ejection fraction and abnormal strain, is common during acute MIS-C.
- Longitudinal data on cardiac outcomes in pediatric MIS-C patients remain limited.
Purpose of the Study:
- To characterize the temporal evolution of cardiac findings in children diagnosed with MIS-C.
- To assess cardiac function and deformation from acute illness through a minimum of 2-month follow-up.
- To identify predictors of cardiac dysfunction and recovery patterns in pediatric MIS-C.
Main Methods:
- Retrospective review of 36 pediatric patients with MIS-C admitted between April 2020 and September 2021.
- Analysis of echocardiographic data, including left ventricular ejection fraction (LVEF) and global longitudinal strain (GLS).
- Cardiac assessments were performed at initial presentation, discharge, 2-4 week, and ≥2-month follow-up visits.
Main Results:
- At presentation, 42% of MIS-C patients had reduced LVEF (<55%), and 44% of those with GLS measured had abnormal strain (< -18%).
- Among patients with normal LVEF at presentation, 22% exhibited abnormal GLS, suggesting subclinical myocardial impairment.
- While 90% of patients with initially reduced LVEF showed normalization by discharge, 21% had persistently abnormal GLS at 2-month follow-up.
Conclusions:
- Myocardial systolic dysfunction and impaired deformation are prevalent in pediatric MIS-C at initial presentation.
- Although LVEF generally recovers by 2 months, persistent abnormalities in GLS suggest ongoing subclinical cardiac dysfunction.
- The study indicates a generally optimistic prognosis for cardiac recovery in MIS-C, but longitudinal monitoring is essential.
Abstract:
Multisystem inflammatory syndrome in children (MIS-C) after COVID-19 is commonly associated with cardiac involvement. Studies found myocardial dysfunction, as measured by decreased ejection fraction and abnormal strain, to be common early in illness. However, there is limited data on longitudinal cardiac outcomes. We aim to describe the evolution of cardiac findings in pediatric MIS-C from acute illness through at least 2-month follow-up. A retrospective single-center review of 36 patients admitted with MIS-C from April 2020 through September 2021 was performed. Echocardiographic data including cardiac function and global longitudinal strain (GLS) were analyzed at initial presentation, discharge, 2-4-week follow-up, and at least 2-month follow-up. Patients with mild and severe disease, normal and abnormal left ventricular ejection fraction (LVEF), and normal and abnormal GLS at presentation were compared. On presentation, 42% of patients with MIS-C had decreased LVEF < 55%. In patients in whom GLS was obtained (N = 18), 44% were abnormal (GLS < |- 18|%). Of patients with normal LVEF, 22% had abnormal GLS. There were no significant differences in troponin or brain natriuretic peptide between those with normal and abnormal LVEF. In most MIS-C patients with initial LVEF < 55% (90%), LVEF normalized upon discharge. At 2-month follow-up, all patients had normal LVEF with 21% having persistently abnormal GLS. Myocardial systolic dysfunction and abnormal deformation were common findings in MIS-C at presentation. While EF often normalized by 2 months, persistently abnormal GLS was more common, suggesting ongoing subclinical dysfunction. Our study offers an optimistic outlook for recovery in patients with MIS-C and carditis, however ongoing investigation for longitudinal effects is warranted.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome III: Diagnostic Studies
Pericarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Myocarditis III: Medical Management


